Predictors of Sustained Virological Response in Chronic Hepatitis C Patients Treated with Current Direct Acting Antiviral Drugs

Outcomes of direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis

Assessment of Degree of Fibrosis in Chronic Hepatitis C Virus Patients Treated with Direct Acting Antiviral Agents

A Study of Hepatocellular Carcinoma in Chronic Hepatitis C Patients Received Direct Acting Antiviral Drugs

Non-invasive Evaluation of Liver Fibrosis Changes in Patients with Chronic ‎Hepatitis C after Directly Acting Antiviral Drugs

Pretreatment serum alpha fetoprotein and its relation to sustained virologic response in patients with chronic HCV infection treated with direct-acting antiviral therapy

Effect of Treating Chronic Hepatitis C Infection with Direct-Acting Antivirals on The Risk of Recurrence Hepatocellular Carcinoma

Hepatocellular Carcinoma in Hepatitis C Virus Cirrhosis After Treatment with Direct Acting Antiviral Therapy

Long-term Follow-up of Chronic Hepatitis C Patients Treated by Direct- Acting Antivirals

Incidence of hepatocellular carcinoma one year after direct acting antiviral therapy for treatment of HCV infection in patients with decompensated liver cirrhosis; A multicenter s